vs
Cytek Biosciences, Inc.(CTKB)与RAPID MICRO BIOSYSTEMS, INC.(RPID)财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是RAPID MICRO BIOSYSTEMS, INC.的5.5倍($62.1M vs $11.3M)。Cytek Biosciences, Inc.净利率更高(-70.9% vs -110.8%,领先39.8%)。RAPID MICRO BIOSYSTEMS, INC.同比增速更快(37.3% vs 8.1%)。Cytek Biosciences, Inc.自由现金流更多($-1.8M vs $-3.3M)。过去两年RAPID MICRO BIOSYSTEMS, INC.的营收复合增速更高(41.8% vs 17.7%)
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。
RAPID MICRO BIOSYSTEMS, INC. 是生命科学领域的技术企业,专注于为生物制药厂商、合同研发生产机构等客户提供自动化微生物检测及质控解决方案,可大幅缩短检测周期、提升检测精度,业务覆盖北美、欧洲、亚太等全球核心市场。
CTKB vs RPID — 直观对比
营收规模更大
CTKB
是对方的5.5倍
$11.3M
营收增速更快
RPID
高出29.2%
8.1%
净利率更高
CTKB
高出39.8%
-110.8%
自由现金流更多
CTKB
多$1.6M
$-3.3M
两年增速更快
RPID
近两年复合增速
17.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $62.1M | $11.3M |
| 净利润 | $-44.1M | $-12.5M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | -108.2% |
| 净利率 | -70.9% | -110.8% |
| 营收同比 | 8.1% | 37.3% |
| 净利润同比 | -557.1% | -29.3% |
| 每股收益(稀释后) | — | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTKB
RPID
| Q4 25 | $62.1M | $11.3M | ||
| Q3 25 | $52.3M | $7.8M | ||
| Q2 25 | $45.6M | $7.3M | ||
| Q1 25 | $41.5M | $7.2M | ||
| Q4 24 | $57.5M | $8.2M | ||
| Q3 24 | $51.5M | $7.6M | ||
| Q2 24 | $46.6M | $6.6M | ||
| Q1 24 | $44.9M | $5.6M |
净利润
CTKB
RPID
| Q4 25 | $-44.1M | $-12.5M | ||
| Q3 25 | $-5.5M | $-11.5M | ||
| Q2 25 | $-5.6M | $-11.9M | ||
| Q1 25 | $-11.4M | $-11.3M | ||
| Q4 24 | $9.6M | $-9.7M | ||
| Q3 24 | $941.0K | $-11.3M | ||
| Q2 24 | $-10.4M | $-12.6M | ||
| Q1 24 | $-6.2M | $-13.3M |
毛利率
CTKB
RPID
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率
CTKB
RPID
| Q4 25 | -9.0% | -108.2% | ||
| Q3 25 | -17.6% | -145.1% | ||
| Q2 25 | -23.3% | -167.3% | ||
| Q1 25 | -36.1% | -161.8% | ||
| Q4 24 | 5.2% | -124.5% | ||
| Q3 24 | -8.2% | -158.3% | ||
| Q2 24 | -18.3% | -202.1% | ||
| Q1 24 | -23.9% | -254.4% |
净利率
CTKB
RPID
| Q4 25 | -70.9% | -110.8% | ||
| Q3 25 | -10.5% | -146.8% | ||
| Q2 25 | -12.2% | -163.3% | ||
| Q1 25 | -27.5% | -156.3% | ||
| Q4 24 | 16.8% | -117.6% | ||
| Q3 24 | 1.8% | -148.9% | ||
| Q2 24 | -22.4% | -190.1% | ||
| Q1 24 | -13.8% | -237.4% |
每股收益(稀释后)
CTKB
RPID
| Q4 25 | — | $-0.26 | ||
| Q3 25 | — | $-0.26 | ||
| Q2 25 | — | $-0.27 | ||
| Q1 25 | — | $-0.26 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | — | $-0.26 | ||
| Q2 24 | — | $-0.29 | ||
| Q1 24 | — | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $20.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $33.2M |
| 总资产 | $461.5M | $74.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CTKB
RPID
| Q4 25 | $90.9M | $20.0M | ||
| Q3 25 | $93.3M | $18.9M | ||
| Q2 25 | $75.5M | $18.3M | ||
| Q1 25 | $95.3M | $18.9M | ||
| Q4 24 | $98.7M | $16.9M | ||
| Q3 24 | $162.3M | $22.0M | ||
| Q2 24 | $177.9M | $37.1M | ||
| Q1 24 | $168.8M | $22.4M |
股东权益
CTKB
RPID
| Q4 25 | $341.7M | $33.2M | ||
| Q3 25 | $378.6M | $44.3M | ||
| Q2 25 | $377.6M | $54.5M | ||
| Q1 25 | $379.6M | $65.5M | ||
| Q4 24 | $395.7M | $75.4M | ||
| Q3 24 | $385.5M | $84.4M | ||
| Q2 24 | $389.1M | $94.6M | ||
| Q1 24 | $392.6M | $105.9M |
总资产
CTKB
RPID
| Q4 25 | $461.5M | $74.9M | ||
| Q3 25 | $494.9M | $84.4M | ||
| Q2 25 | $493.3M | $75.6M | ||
| Q1 25 | $482.6M | $85.4M | ||
| Q4 24 | $499.5M | $98.2M | ||
| Q3 24 | $491.2M | $105.8M | ||
| Q2 24 | $483.7M | $117.1M | ||
| Q1 24 | $492.1M | $127.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $-3.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-3.3M |
| 自由现金流率自由现金流/营收 | -2.9% | -29.6% |
| 资本支出强度资本支出/营收 | 1.6% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $-31.9M |
8季度趋势,按日历期对齐
经营现金流
CTKB
RPID
| Q4 25 | $-771.0K | $-3.2M | ||
| Q3 25 | $-3.9M | $-9.1M | ||
| Q2 25 | $108.0K | $-9.7M | ||
| Q1 25 | $-125.0K | $-9.1M | ||
| Q4 24 | $2.0M | $-9.9M | ||
| Q3 24 | $13.2M | $-8.6M | ||
| Q2 24 | $6.2M | $-10.1M | ||
| Q1 24 | $4.0M | $-15.5M |
自由现金流
CTKB
RPID
| Q4 25 | $-1.8M | $-3.3M | ||
| Q3 25 | $-4.6M | $-9.1M | ||
| Q2 25 | $-1.5M | $-10.1M | ||
| Q1 25 | $-974.0K | $-9.4M | ||
| Q4 24 | $1.1M | $-10.0M | ||
| Q3 24 | $12.2M | $-8.8M | ||
| Q2 24 | $5.2M | $-10.6M | ||
| Q1 24 | $3.4M | $-16.1M |
自由现金流率
CTKB
RPID
| Q4 25 | -2.9% | -29.6% | ||
| Q3 25 | -8.7% | -116.4% | ||
| Q2 25 | -3.2% | -138.6% | ||
| Q1 25 | -2.3% | -130.2% | ||
| Q4 24 | 1.9% | -121.8% | ||
| Q3 24 | 23.7% | -116.0% | ||
| Q2 24 | 11.0% | -159.8% | ||
| Q1 24 | 7.6% | -287.1% |
资本支出强度
CTKB
RPID
| Q4 25 | 1.6% | 0.8% | ||
| Q3 25 | 1.3% | 0.9% | ||
| Q2 25 | 3.5% | 5.0% | ||
| Q1 25 | 2.0% | 4.4% | ||
| Q4 24 | 1.6% | 1.2% | ||
| Q3 24 | 2.0% | 2.9% | ||
| Q2 24 | 2.3% | 6.9% | ||
| Q1 24 | 1.3% | 10.4% |
现金转化率
CTKB
RPID
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RPID
| Products | $9.3M | 83% |
| Services | $2.0M | 17% |